AstraZeneca reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AstraZeneca using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AZN | AstraZeneca | $1.07 | $1.20 | $0.99 | -17.50% | $11.42B | $12.75B | $12.98B | 1.83% | 07/25/2024 | Get Alert |
AZN | AstraZeneca | $0.96 | $1.22 | $1.03 | -15.57% | $10.88B | $11.83B | $12.68B | 7.18% | 04/25/2024 | Get Alert |
AZN | AstraZeneca | $0.69 | $0.79 | $0.72 | -8.23% | $11.21B | $12.09B | $12.02B | -0.55% | 02/08/2024 | Get Alert |
AZN | AstraZeneca | $0.84 | $0.84 | $0.86 | 2.98% | $10.98B | $11.66B | $11.49B | -1.44% | 11/09/2023 | Get Alert |
AZN | AstraZeneca | $0.86 | $0.95 | $1.07 | — | $10.77B | $10.96B | $11.42B | 4.16% | 07/28/2023 | Get Alert |
AZN | AstraZeneca | $1.89 | $1.07 | $0.96 | -10.28% | $11.39B | $10.75B | $10.88B | 1.20% | 04/27/2023 | Get Alert |
AZN | AstraZeneca | $0.84 | $0.67 | $0.69 | 2.99% | $12.01B | $11.21B | $11.21B | -0.03% | 02/09/2023 | Get Alert |
AZN | AstraZeneca | $1.07 | $0.72 | $0.84 | 16.67% | $9.87B | $10.91B | $10.98B | 0.66% | 11/10/2022 | Get Alert |
AZN | AstraZeneca | $0.45 | $0.77 | $0.86 | 11.69% | $8.22B | $10.53B | $10.77B | 2.29% | 07/29/2022 | Get Alert |
AZN | AstraZeneca | $0.82 | $0.83 | $0.95 | 14.46% | $7.32B | $10.99B | $11.39B | 3.64% | 04/29/2022 | Get Alert |
AZN | AstraZeneca | $0.54 | $0.73 | $0.84 | 15.07% | $7.41B | $10.88B | $12.01B | 10.40% | 02/10/2022 | Get Alert |
AZN | AstraZeneca | $0.47 | $0.62 | $0.54 | -12.90% | $6.58B | $9.87B | $9.87B | -0.04% | 11/12/2021 | Get Alert |
AZN | AstraZeneca | $0.48 | $0.43 | $0.45 | 4.65% | $6.28B | $7.36B | $8.22B | 11.68% | 07/29/2021 | Get Alert |
AZN | AstraZeneca | $1.05 | $0.75 | $0.82 | 9.33% | $6.35B | $7.08B | $7.32B | 3.39% | 04/30/2021 | Get Alert |
AZN | AstraZeneca | $0.45 | $0.68 | $0.54 | -20.59% | $6.66B | $6.97B | $7.41B | 6.31% | 02/11/2021 | Get Alert |
AZN | AstraZeneca | $0.99 | $0.44 | $0.47 | 6.82% | $6.41B | $6.65B | $6.58B | -1.08% | 11/05/2020 | Get Alert |
AZN | AstraZeneca | $0.73 | $0.44 | $0.48 | 9.09% | $5.82B | $6.24B | $6.28B | 0.56% | 07/30/2020 | Get Alert |
AZN | AstraZeneca | $0.89 | $0.47 | $0.53 | 12.77% | $5.49B | $5.90B | $6.35B | 7.69% | 04/29/2020 | Get Alert |
AZN | AstraZeneca | $1.58 | $0.59 | $0.45 | -23.73% | $6.42B | $6.75B | $6.66B | -1.27% | 02/14/2020 | Get Alert |
AZN | AstraZeneca | $0.71 | $0.45 | $0.99 | 120.00% | $5.34B | $6.18B | $6.41B | 3.66% | 10/24/2019 | Get Alert |
AZN | AstraZeneca | $0.69 | $0.29 | $0.73 | 151.72% | $5.16B | $5.51B | $5.82B | 5.68% | 07/25/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $0.99 | $1.20 | -17.5 % |
Mar 2024 | 2024-04-25 | $1.03 | $1.22 | -15.6 % |
Dec 2023 | 2024-02-08 | $0.73 | $0.79 | -8.23 % |
Sep 2023 | 2023-11-09 | $0.87 | $0.84 | 2.98 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $12.98B | $12.75B | 1.83 % |
Mar 2024 | 2024-04-25 | $12.68B | $11.83B | 7.18 % |
Dec 2023 | 2024-02-08 | $12.02B | $12.09B | -0.55 % |
Sep 2023 | 2023-11-09 | $11.49B | $11.66B | -1.44 % |
AstraZeneca ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on July 25, 2024 for Q2.
AstraZeneca ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on July 25, 2024 for Q2 and the Actual EPS was $0.99, which missed the estimate of $1.20.
AstraZeneca ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on July 25, 2024 for Q2 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.